Bio Green Med Solution Inc. said Nasdaq has determined its 6% Convertible Exchangeable Preferred Stock $(BGMSP)$ no longer meets the exchange’s continued listing requirement for a minimum $1 million market value of publicly held shares and will be delisted. The company does not plan to appeal; trading is expected to be suspended March 23, 2026, with delisting anticipated on or after April 2, 2026, and potential trading to move to OTC Markets. The notice does not affect the company’s Nasdaq-listed common stock (BGMS).
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio Green Med Solution Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-009991), on March 13, 2026, and is solely responsible for the information contained therein.